We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+0.38%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$40.7B
AUM Growth
+$1.22B
Cap. Flow
+$984M
Cap. Flow %
2.42%
Top 10 Hldgs %
29.3%
Holding
1,190
New
178
Increased
257
Reduced
455
Closed
177

Sector Composition

Rank Sector Weight
1 Technology 19.67%
2 Financials 12.44%
3 Consumer Discretionary 12.42%
4 Healthcare 11.6%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARW icon
826
Arrow Electronics
ARW
$10.4B
$7K ﹤0.01%
104
BBT
827
Beacon Financial Corp
BBT
$2.66B
$7K ﹤0.01%
+201
New +$6.46K
BW icon
828
Babcock & Wilcox
BW
$1.39B
$7K ﹤0.01%
42
-71,564
-100% -$11.4M
HCI icon
829
HCI Group
HCI
$2.41B
$7K ﹤0.01%
+166
New +$5.3K
IVR icon
830
Invesco Mortgage Capital
IVR
$805M
$7K ﹤0.01%
+51
New +$7.56K
MXL icon
831
MaxLinear
MXL
$6.8B
$7K ﹤0.01%
300
PIPR icon
832
Piper Sandler
PIPR
$5.29B
$7K ﹤0.01%
+404
New +$6.38K
RGEN icon
833
Repligen
RGEN
$9.25B
$7K ﹤0.01%
223
+92
+70% +$2.85K
SCSC icon
834
Scansource
SCSC
$1.12B
$7K ﹤0.01%
185
+152
+461% +$5.66K
STNG icon
835
Scorpio Tankers
STNG
$3.81B
$7K ﹤0.01%
+155
New +$6.68K
TBI
836
Trueblue
TBI
$311M
$7K ﹤0.01%
282
MTOR
837
DELISTED
MERITOR, Inc.
MTOR
$7K ﹤0.01%
+566
New +$6.66K
FPRX
838
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$7K ﹤0.01%
130
HSKA
839
DELISTED
Heska Corp
HSKA
$7K ﹤0.01%
97
ACIW icon
840
ACI Worldwide
ACIW
$5.42B
$6K ﹤0.01%
344
-320
-48% -$5.99K
ANF icon
841
Abercrombie & Fitch
ANF
$5B
$6K ﹤0.01%
526
-146
-22% -$2.17K
ANIP icon
842
ANI Pharmaceuticals
ANIP
$1.78B
$6K ﹤0.01%
103
ARCB icon
843
ArcBest
ARCB
$3.08B
$6K ﹤0.01%
205
ASRT
844
DELISTED
Assertio
ASRT
$6K ﹤0.01%
5
CMRE icon
845
Costamare
CMRE
$1.77B
$6K ﹤0.01%
+992
New +$6.58K
CNS icon
846
Cohen & Steers
CNS
$4.3B
$6K ﹤0.01%
+193
New +$7.05K
ENS icon
847
EnerSys
ENS
$6.99B
$6K ﹤0.01%
80
-67,576
-100% -$4.96M
GMED icon
848
Globus Medical
GMED
$11.2B
$6K ﹤0.01%
260
ORA icon
849
Ormat Technologies
ORA
$6.65B
$6K ﹤0.01%
+109
New +$5.29K
PFSI icon
850
PennyMac Financial
PFSI
$4.02B
$6K ﹤0.01%
+359
New +$6.11K

Similar funds

Loomis, Sayles & Company's Q4 2016 Portfolio in Review

As of Q4 2016, Loomis, Sayles & Company held 1,190 positions worth $40.7B, up 3.1% from $39.5B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Loomis, Sayles & Company's Q4 2016 filing shows 178 new, 257 increased, 455 reduced and 177 closed positions. Its largest new stake was Yum China: 10,852,792 shares worth $283M. The largest sale was Yum! Brands, an estimated $128M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Loomis, Sayles & Company's largest Q4 2016 buy was Yum China: 10,852,792 shares worth $283M.
  • Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2016, an estimated $216M increase.
  • Loomis, Sayles & Company's biggest Q4 2016 reduction was Yum! Brands, cutting an estimated $128M.
  • Loomis, Sayles & Company fully exited Alcoa Inc in Q4 2016, selling an estimated $71.7M.
  • Loomis, Sayles & Company's ten largest holdings make up 29% of its $40.7B portfolio in Q4 2016.
  • Loomis, Sayles & Company opened 178 new positions and closed 177 in Q4 2016.
  • Loomis, Sayles & Company's portfolio value rose 3.1% quarter-over-quarter to $40.7B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2016, filed 14 Feb 2017.